Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000711377-05-000019
Filing Date
2005-07-13
Accepted
2005-07-13 13:02:02
Documents
1
Period of Report
2005-05-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3140
  Complete submission text file 0000711377-05-000019.txt   4907
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Issuer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address C/O NEOGEN CORP 620 LESHER PLACE LANSING MI 48912 5173729200
BRADLEY EDWARD (Reporting) CIK: 0001189021 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-17988 | Film No.: 05951881